浏览/检索结果:共3条，第1-3条

已选(0)清除条数/页：排序方式：
	Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients 期刊论文 Frontiers in Oncology,2022, 卷号: 12 作者: Fang，Chao; Fang，Wenfeng; Xu，Liqin; Gao，Fangfang; Hou，Yong 收藏 \| 浏览/下载：19/0 \| 提交时间：2025/07/18 anti-PD-1 biomarker gut microbiome immune checkpoint therapy lung cancer
	Neoadjuvant camrelizumab, nab-paclitaxel, and carboplatin in patients with stage IB-IIIA non-small cell lung cancer (NANE-LC): A study protocol of prospective, single-arm, multicenter, phase II study 期刊论文 Journal of Thoracic Disease,2021, 卷号: 13, 期号: 11, 页码: 6468-6475 作者: Zhou, Haiyu; Lin, Lili; Qin, Tao; Ren, Wei; Tan, Yujie 收藏 \| 浏览/下载：34/0 \| 提交时间：2022/02/23 Artificial intelligence Checkpoint inhibitors Immune Major pathological response Neoadjuvant therapy Non-small cell lung cancer (NSCLC)
	Air pollution and lung cancer incidence in China: Who are faced with a greater effect? 期刊论文 Environment International,2019, 卷号: 132 作者: Guo, Huagui; Chang, Zheng; Wu ,Jiansheng; Li, Weifeng 收藏 \| 浏览/下载：29/0 \| 提交时间：2022/06/13 Air pollution China Lung cancer incidence Modification effects